Founding offer · lifetime membership for a single £24, exclusive to our first members · closes 20 June Claim your place →
Global Research Partnerships £24 Lifetime Log inCreate free account

Funded Projects › FP7

IN-SENS · Deciphering inter- and intracellular signalling in schizophrenia

FP7Status: CLOSED1 October 201330 September 2017EU funding €3,918,138

IN-SENS is an interdisciplinary, cutting-edge European industry-academia collaborative effort for a novel training of scientists in molecular psychiatry with the prospect of discovering the biology of schizophrenia and actively promote drug discovery. Mental illnesses are a major burden to patients, relatives, and public health worldwide. IN-SENS therefore aims to profoundly change the academic-industry research landscape in European psychiatry by an unprecedented, innovative strategy.The extended intra- and intercellular signalling pathway of disrupted-in-schizophrenia 1 (DISC1), the best characterized gene known to cause schizophrenia and other chronic mental illnesses (CMI), will be used as a molecular Rosetta stone for this purpose. Expected results of IN-SENS include profound training, including clinical psychiatry, industrial, and translational medicine exposure, of a new generation of European ESRs capable of understanding the molecular underpinnings of CMI in academia, industry and other non-academic sectors. ESRs will explore how molecules related to the extended DISC1 pathway translate to the different biochemical, genetic, and neurodevelopmental hypotheses and data proposed so far as being important players in the molecular pathology of CMI. Further, they will play an active role in the generation of new analytical tools and therapeutic agents for the diagnosis and treatment of CMI in close collaboration with the industrial sector.IN-SENS will have immediate and longterm benefits for the European academic-industry research landscape in psychiatry by fostering scientific creativity and entrepreneurial skills of ESRs, generating novel research networks in Europe, enhancing mutual recognition and introducing novel models and of public-private cooperations. At the end of IN-SENS, exceptionally trained ESRs will be ready to extend these studies in academia and/or the private sector, and be able to move confidently to a fruitful professional career.

Consortium · 13 organisations

coordinator

HEINRICH-HEINE-UNIVERSITAET DUESSELDORF

DE · €656,445

participant

INSTITUTE OF SCIENCE AND TECHNOLOGY AUSTRIA

AT · €240,202

participant

LUDWIG-MAXIMILIANS-UNIVERSITAET MUENCHEN

DE · €222,069

participant

HELSINGIN YLIOPISTO

FI · €261,198

participant

KUNGLIGA TEKNISKA HOEGSKOLAN

SE · €259,925

participant

STICHTING VU

NL · €478,123

participant

IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE

UK · €285,057

participant

ASTRAZENECA AB

SE · €154,312

participant

F. HOFFMANN-LA ROCHE AG

CH · €155,346

participant

UNIVERSITEIT MAASTRICHT

NL · €236,861

participant

UNIVERSIDAD DE SANTIAGO DE COMPOSTELA

ES · €226,682

participant

SYNAPTOLOGICS BV

NL · €456,861

participant

THE UNIVERSITY OF EDINBURGH

UK · €285,057

Research fields

View the official record on CORDIS →

← Find collaborators and more funded projects

Source: CORDIS, Publications Office of the European Union. Global Research Partnerships surfaces open EU research data to help you find collaborators; we are not affiliated with the European Union.